Literature DB >> 25486914

The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology.

Alice B Gottlieb1, Adriane A Levin2, April W Armstrong3, April Abernethy4, Kristina Callis Duffin5, Reva Bhushan6, Amit Garg7, Joseph F Merola8, Mara Maccarone9, Robin Christensen10.   

Abstract

As quality standards are increasingly in demand throughout medicine, dermatology needs to establish outcome measures to quantify the effectiveness of treatments and providers. The International Dermatology Outcome Measures Group was established to address this need. Beginning with psoriasis, the group aims to create a tool considerate of patients and providers using the input of all relevant stakeholders in assessment of disease severity and response to treatment. Herein, we delineate the procedures through which consensus is being reached and the future directions of the project.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Delphi exercises; Dermatology Life Quality Index; International Dermatology Outcome Measures; National Psoriasis Foundation; Outcome Measures in Rheumatology; Physician Global Assessment; Psoriasis Area and Severity Index; body surface area; disease severity; patient-centered outcome measures; psoriasis; psoriatic arthritis; quality of life

Mesh：

Year:  2014        PMID： 25486914     DOI： 10.1016/j.jaad.2014.11.002

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  9 in total

1.  Physician-Centered Outcomes for Skin Cancer Treatment: A Single-Day Modified Delphi Process to Assess the Importance of Themes in Skin Cancer Management.

Authors:  Anthony M Rossi; Joseph Sobanko; Naomi Lawrence; Jeremy Bordeaux; Todd Cartee; Eric S Armbrecht; Anit Behera; Christian L Baum; Murad Alam; Ian A Maher
Journal:  Dermatol Surg       Date:  2019-07       Impact factor: 3.398

2.  Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials.

Authors:  Kristina Callis Duffin; Joseph F Merola; Robin Christensen; John Latella; Amit Garg; Alice B Gottlieb; April W Armstrong
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

3.  Patient-Centered Outcomes for Skin Cancer Management: Utilization of a Patient Delphi Process to Identify Important Treatment Themes.

Authors:  Todd V Cartee; Murad Alam; Eric S Armbrecht; Anit Behera; Naomi Lawrence; Jeremy S Bordeaux; Christian L Baum; Anthony Rossi; Ian A Maher
Journal:  Dermatol Surg       Date:  2019-02       Impact factor: 3.398

Review 4.  International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.

Authors:  Alison H Kohn; Afsaneh Alavi; April W Armstrong; Folawiyo Babalola; Amit Garg; Alice B Gottlieb; Lesley Grilli; Gregor Borut Ernst Jemec; John Latella; Kendall Marcus; Joseph F Merola; Alex G Ortega-Loayza; Daniel M Siegel; Vibeke Strand; Jerry K L Tan; Lourdes M Perez-Chada
Journal:  Dermatology       Date:  2021-09-17       Impact factor: 5.197

Review 5.  Report from the International Dermatology Outcome Measures Initiative.

Authors:  Lourdes M Perez-Chada; Joseph F Merola; April W Armstrong; Amit Garg; John Latella; Alice B Gottlieb
Journal:  J Investig Dermatol Symp Proc       Date:  2020-11

6.  Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient-reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials.

Authors:  D Thaçi; A Kimball; P Foley; Y Poulin; E Levi; R Chen; S R Feldman
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-10-10       Impact factor: 6.166

7.  Clinical outcome measures and scoring systems used in prospective studies of port wine stains: A systematic review.

Authors:  M Ingmar van Raath; Sandeep Chohan; Albert Wolkerstorfer; Chantal M A M van der Horst; Jacqueline Limpens; Xuan Huang; Baoyue Ding; Gert Storm; René R W J van der Hulst; Michal Heger
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

Review 8.  Expert Consensus on the Use of Prognostic Gene Expression Profiling Tests for the Management of Cutaneous Melanoma: Consensus from the Skin Cancer Prevention Working Group.

Authors:  Aaron S Farberg; Justin W Marson; Alex Glazer; Graham H Litchman; Ryan Svoboda; Richard R Winkelmann; Nicholas Brownstone; Darrell S Rigel
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-30

9.  Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project).

Authors:  G B Langbroek; A Wolkerstorfer; S E R Horbach; P I Spuls; K M Kelly; S J Robertson; M I van Raath; F Al-Niaimi; T Kono; P Boixeda; H J Laubach; A M Badawi; A Troilius Rubin; M Haedersdal; W Manuskiatti; C M A M van der Horst; D T Ubbink
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-16       Impact factor: 6.166
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.